Open access · CC-BY
via OpenAlex
Chronic hyperinsulinemia promotes human hepatocyte senescence
Ritesh Kumar Baboota, Rosa Spinelli, Malin C. Erlandsson, Bruna Brasil Brandão, Marsel Lino, Hong Yang, Adil Mardinoğlu, Maria I Bokarewa, Jérémie Boucher, C. Ronald Kahn, Ulf Smith
Molecular Metabolism · 2022 · ▲ 47 citations
Deregulated nutrient-sensing
Cellular senescence
Altered intercellular communication
Senolytics
Cell culture / in vitro
Human
Mouse
In vitro
Abstract
OBJECTIVE: Cellular senescence(definition), an irreversible proliferative cell arrest, is caused by excessive intracellular or extracellular stress/damage. Increased senescent cells have been identified in multiple tissues in different metabolic and other aging-related diseases. Recently, several human and mouse studies emphasized the involvement of senescence in development and progression of NAFLD. Hyperinsulinemia, seen in obesity, metabolic syndrome, and other conditions of insulin resistance, has been linked to senescence in adipocytes and neurons. Here, we investigate the possible direct role of chronic hyperinsulinemia in the development of senescence in human hepatocytes. METHODS: Using fluorescence microscopy, immunoblotting, and gene expression, we tested senescence markers in human hepatocytes subjected to chronic hyperinsulinemia in vitro and validated the data in vivo by using liver-specific insulin receptor knockout (LIRKO) mice. The consequences of hyperinsulinemia were also studied in senescent hepatocytes following doxorubicin as a model of stress-induced senescence. Furthermore, the effects of senolytic agents in insulin- and doxorubicin-treated cells were analyzed. RESULTS: Results showed that exposing the hepatocytes to prolonged hyperinsulinemia promotes the onset of senescence by increasing the expression of p53 and p21. It also further enhanced the senescent phenotype in already senescent hepatocytes. Addition of insulin signaling pathway inhibitors prevented the increase in cell senescence, supporting the direct contribution of insulin. Furthermore, LIRKO mice, in which insulin signaling in the liver is abolished due to deletion of the insulin receptor gene, showed no differences in senescence compared to their wild-type counterparts despite having marked hyperinsulinemia indicating these are receptor-mediated effects. In contrast, the persistent hyperinsulinemia in LIRKO mice enhanced senescence in white adipose tissue. In vitro, senolytic agents dasatinib and quercetin reduced the prosenescent effects of hyperinsulinemia in hepatocytes. CONCLUSION: Our findings demonstrate a direct link between chronic hyperinsulinemia and hepatocyte senescence. This effect can be blocked by reducing the levels of insulin receptors or administration of senolytic drugs, such as dasatinib and quercetin.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.molmet.2022.101558
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Baboota, R.K., Spinelli, R., Erlandsson, M.C., Brandão, B.B., Lino, M., Yang, H., Mardinoğlu, A., Bokarewa, M.I., Boucher, J., Kahn, C.R., & Smith, U. (2022). Chronic hyperinsulinemia promotes human hepatocyte senescence. <em>Molecular Metabolism</em>. https://doi.org/10.1016/j.molmet.2022.101558
Vancouver
Baboota RK, Spinelli R, Erlandsson MC, Brandão BB, Lino M, Yang H, et al. Chronic hyperinsulinemia promotes human hepatocyte senescence. Molecular Metabolism. 2022. doi:10.1016/j.molmet.2022.101558.
BibTeX
@article{ritesh2022Chroni,
title = {Chronic hyperinsulinemia promotes human hepatocyte senescence},
author = {Ritesh Kumar Baboota and Rosa Spinelli and Malin C. Erlandsson and Bruna Brasil Brandão and Marsel Lino and Hong Yang and Adil Mardinoğlu and Maria I Bokarewa and Jérémie Boucher and C. Ronald Kahn and Ulf Smith},
journal = {Molecular Metabolism},
year = {2022},
doi = {10.1016/j.molmet.2022.101558},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Institutional Repositories DataBase (IRDB) 2025
Preprint · CC-BY
ダサチニブとケルセチンは老化細胞除去剤として、代謝機能障害関連脂肪性肝疾患メダカモデルにおいて脂肪沈着の改善、抗線維化効果を示す
Diseases 2024
Open access · CC-BY
Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model
Molecular Metabolism 2024
Open access · CC-BY
Senescent cell depletion alleviates obesity-related metabolic and cardiac disorders
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature 2019
Preprint
Faculty Opinions recommendation of Fisetin is a senotherapeutic that extends health and lifespan.
Arteriosclerosis Thrombosis and Vascular Biology 2026
Citation only
Abstract Thu073: Senolytic drugs, dasatinib and quercetin, ameliorate age- and obesity-related metabolic and arterial dysfunction
PNAS Nexus 2025
Open access · CC-BY